[1]
“Takotsubo Syndrome Associated With Osimertinib In A Patient With Non-Small Cell Lung Cancer: A Case Report”, Rev. colomb. hematol. oncol. , vol. 9, no. Supl, pp. 242–243, Jun. 2023, doi: 10.51643/22562915.636.